findmyKOL
Clinical trialNCT01246908CompletedPhase 2Interventional

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

SponsorCeNeRx BioPharma Inc.Enrollment360Treatment Resistant Depression
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Synergy Escondido

    Escondido, California, United States

  • Synergy Clinical Research Center

    National City, California, United States

  • Excell Research

    Oceanside, California, United States

  • Pacific Clinical Research

    Orange, California, United States

  • Gulfcoast Clinical Research Center

    Fort Myers, Florida, United States

  • Clinical Neuroscience Solutions, Inc.

    Jacksonville, Florida, United States

  • the Segal Institute of Clinical Research

    North Miami, Florida, United States

  • Clinical Neuroscience Solutions, Inc.

    Orlando, Florida, United States

  • Stedman Clinical Trials

    Tampa, Florida, United States

  • University of South Florida College of Medicine Psychiatry Center

    Tampa, Florida, United States

  • Kolin Research Group

    Winter Park, Florida, United States

  • Atlanta Institute of Medicine and Research

    Atlanta, Georgia, United States

  • Nathan Shapira, Md, Ph.D

    Smyrna, Georgia, United States

  • Mclean Hospital

    Belmont, Massachusetts, United States

  • Accelrx Research

    Fall River, Massachusetts, United States

  • Eastside Comprehensive Medical Center

    New York, New York, United States

  • Richard H. Weisler, M.D. and Associates

    Raleigh, North Carolina, United States

  • Northcoast Clinical Trials, Inc.

    Beachwood, Ohio, United States

  • Patient Priority Clinical Sites, Llc

    Cincinnati, Ohio, United States

  • North Star Medical Research, Llc

    Middleburg Heights, Ohio, United States

  • Oregon Center for Clinical Investigations, Inc

    Portland, Oregon, United States

  • Summitt Research Network (oregon)

    Portland, Oregon, United States

  • Introspect of Buxmont, Ltd

    Colmar, Pennsylvania, United States

  • Clinical Neurosciences Solutions, Inc.

    Memphis, Tennessee, United States

  • Community Clinical Research, Inc.

    Austin, Texas, United States

  • Futuresearch Trials of Dallas

    Dallas, Texas, United States

  • Radiant Research

    Murray, Utah, United States

  • Northwest Clinical Research Center

    Bellevue, Washington, United States

  • Summit Research Network (seattle) Llc

    Seattle, Washington, United States

  • Northbrooke Research Center

    Deer Brown, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2010
Primary completion
31 May 2012
Completion
31 May 2012
Last update posted
10 Jul 2012
Registered enrollment
360
Registry id
NCT01246908

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.